Virtual Reality Avatar Therapy for People Hearing Voices

Last updated: September 26, 2023
Sponsor: Psychiatric University Hospital, Zurich
Overall Status: Active - Recruiting

Phase

N/A

Condition

Schizophrenia And Schizoaffective Disorders (Pediatric)

Affective Disorders

Schizotypal Personality Disorder (Spd)

Treatment

Assertiveness Training Program (ATP)

Virtual Reality Avatar Therapy (VRAT)

Clinical Study ID

NCT04099940
VRAT- ATP
  • Ages 18-65
  • All Genders

Study Summary

Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Consistent acoustic hallucinations, with the presence of voices for at least twomonths.
  • Participants are competent to give informed consent, as determined by the referringphysician or psychiatrist.
  • German language proficiency as a native speaker or level B1 Common European Frameworkof Reference for Languages (CEFRL)

Exclusion

Exclusion Criteria:

  • Current neurological disorder.
  • Current substance use or withdrawal.
  • Concomitant group psychotherapeutic intervention.

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Assertiveness Training Program (ATP)
Phase:
Study Start date:
July 01, 2021
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Psychiatrische Universitätsklinik Zürich

    Zürich, 8032
    Switzerland

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.